Error loading player: No playable sources found

Characterization of Adeno-Associated Viruses and Lipid Nanoparticles - Technical Seminar Sponsored by SCIEX

Date
June 7, 2021
This product is not available for individual purchase, but it is available as part of the following products:
Thumbnail for Cell & Gene Therapy Products 2021
The CGTP 2021 Symposium will explore how to continue to adapt concepts applied to other biologics and how to establish novel approaches where they are needed.

In-depth characterization of Adeno-Associated Virus (AAV) is important for quality assurance and safety of AAV products in gene therapy industry. Capillary Electrophoresis (CE) is a technology which could provide fast, reliable and robust analysis of AAV capsid protein purity with high sensitivity, AAV full and empty ratio determination, AAV charge variants and integrity analysis of genome packaged in AAV capsids which are critical workflows for AAV product analysis. Additionally, advancements in pharmaceutical development have led to novel ways in which therapeutics are delivered. Emerging drug delivery mechanisms are liposomes, currently being utilized as therapeutic transport systems. The expansion of liposomes to more specialized lipid nanoparticles (LNPs) has further developed this area of therapeutics and LC-MS has emerged as a robust technique for their profiling and quantification.

Session Speaker


Related Products

Thumbnail for Session VI – Deep Dive Discussion
Session VI – Deep Dive Discussion
Join Session VI Deep Dive Panel Discussion [https://live.remo…
Thumbnail for Session V – Deep Dive Discussion
Session V – Deep Dive Discussion
Join Session V Deep Dive Panel Discussion [https://live.remo…
Thumbnail for Characterization of Adeno-Associated Viruses (Aavs) Using LC/MS - Technical Seminar Sponsored by Waters Corporation
Characterization of Adeno-Associated Viruses (Aavs) Using LC/MS - Technical Seminar Sponsored by Waters Corporation
Adeno-associated virus (AAV) has been widely used in gene therapy applications…
Thumbnail for Session V – Case Studies from Global CGTP Submissions
Session V – Case Studies from Global CGTP Submissions
This session will cover cell and gene therapy products in late stage of development and approved by the FDA and/or EMA to demonstrate the main CMC challenges, the regulatory framework, and the overall experience with the Health Authorities to bring these medicines to patients…